ArticleJournal, genetic engineering & biotechnology2025
NanoFlora: Unveiling the therapeutic potential of Ipomoea aquatica nanoparticles.
Article in Journal, genetic engineering & biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Biosynthesized Silver Nanoparticles and Their Antidiabetic Potential.Pharmaceuticals (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionImproving the pharmacokinetics of drugs is achieved through nano formulations and the role of natural product in the synthesis of nanomaterials is gaining prominence due to its eco-friendly nature, cost-effectiveness, and demonstrated efficacy. Metal nanoparticles (NPs) derived from Ipomoea aquatica Forsskal have been synthesized and evaluated for their antioxidant and antidiabetic properties towards enhancing the anticancer activity of the plant extracts. METHODOLOGY: Hydroalcoholic extract was obtained from the entire Ipomoea aquatica plant and utilized as a key ingredient in the green synthesis of metal NPs. The characterization of the synthesized NPs involved UV/visible and FT-IR spectroscopic analyses, along with particle size determination using Zetasizer technology. Antioxidant activity was assessed through DPPH radical scavenging assays, while antidiabetic potential was evaluated via alpha-amylase inhibitory activity using HPTLC bioautography.
resultsThe formation of silver nanoparticles (AgNPs) was confirmed by a color change from light brown to dark brown. UV-VIS spectrum analysis showed strong absorbance between 380 and 400 nm, with a peak at 428 nm, indicating successful synthesis via bioreduction by Ipomoea aquatica extract. FT-IR spectra revealed phytochemicals like flavonoids and proteins, with shifts in peak positions confirming AgNP formation. DLS showed an average particle size of 36.27 nm, and TEM images confirmed spherical morphology. The AgNPs exhibited significant antioxidant and antidiabetic activities, outperforming standards such as ascorbic acid and Glibenclamide. Toxicity prediction identified the extract as slightly toxic, guiding safe dose administration.
conclusionThe study underscores the potential of plant-based nanoparticles in scavenging free radicals and supporting cytotoxicity, thus hinting at their potential role in cancer therapy. Moreover, the nanoparticles derived from Ipomoea aquatica exhibit promising antioxidant and antidiabetic activities compared to the crude plant extract. This research paves the way for further exploration of Ipomoea aquatica nanoparticles as a novel therapeutic intervention for various diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.